Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Launched by CHANG GUNG MEMORIAL HOSPITAL · Jul 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new tool, called an 18 mm short vitrectomy probe, to see how safe and effective it is for eye surgeries in children. The trial focuses on children with various eye conditions, such as retinopathy of prematurity and other retinal diseases. Researchers also want to know how comfortable and reliable surgeons feel using this shorter probe compared to traditional tools.

To participate, children must be under 18 years old and need vitrectomy surgery for specific eye problems. However, children who cannot cooperate with eye exams will not be eligible. If chosen to participate, families can expect close monitoring during the surgery and follow-up visits to ensure safety and effectiveness. This study is currently recruiting participants, and it aims to improve treatment options for young patients with serious eye conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients less than 18 years old
• • Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.
• Exclusion Criteria:
• • Patients who cannot cooperate fully with detailed ophthalmic examinations.